Reporter gene technology to assess activity of antimycobacterial agents in macrophages

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 6, 1996, Pages 1542-1544

  Arain, Taraq M ^a   Resconi, Anna E ^a   Singh, Devinder C ^a   Stover, C Kendall ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BIOLUMINESCENCE; HUMAN; HUMAN CELL; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TUBERCULOSIS;

EID: 0029889188     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.6.1542     Document Type: Article

References (11)

1. Arain, T. M., A. E. Resconi, M. J. Hickey, and C. K. Stover. 1996. Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. Antimicrob. Agents Chemother. 40:1534-1539
2. Clini, V., and C. Grassi. 1970 The action of new antituberculous drugs on intracellular tubercle bacilli. Antibiot. Chemother. (Basel) 16:20-26.
3. Cooksey, R. C., J. T. Crawford, W. R. Jacobs, Jr., and T. M. Shinnick. 1993. A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob. Agents Chemother. 37:1348-1352.
4. Dhillon, J., and D. A. Mitchison. 1992 Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages Am. Rev. Respir. Dis. 145:212-214
5. Hickey, M. J., T. M. Arain, R. M. Shawar, D. J. Humble, M. H. Langhorne, J. N. Morgenroth, and C. K. Stover. 1996. Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob. Agents Chemother. 40:400-407.
6. Jacobs, W. R., Jr., R. G. Barletta, R. Udani, J. Chan, G. Kalkut, G. Sosne, T. Kieser, G. J. Sarkis, G. F. Hatfull, and B. R. Bloom. 1993. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages Science 260:819-822.
7. Johnson, J. D., W. L. Hand, J. B. Francis, N. Jing-Thompson, and R. W. Corwin. 1980 Antibiotic uptake by alveolar macrophages. J. Lab. Clin. Med 95:429-439.
8. Mor, N., and L. Heifets. 1993. MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages. Antimicrob. Agents Chemother 37:111-114
9. Onyeji, C. O., C. H. Nightingale, D. P. Nicolau, and R. Quintiliani. 1994 Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages. Antimicrob. Agents Chemother. 38:523-527.
10. Prokesch, R. C., and W. L. Hand. 1982. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob. Agents Chemother 21:373-380.
11. Sbarbaro, J. A., M. D. Iseman, and A. J. Crowle. 1992. The combined effect of rifampin and pyrazinamide within the human macrophage. Am. Rev Respir. Dis. 146:1448-1451.